EQS-News: Semperit nach Transformationsjahr gestärkt für weiteres Wachstum – Ergebnis 2023 noch vom verkauften Medizingeschäft belastet
Retrieved on:
Wednesday, April 10, 2024
Earnings after tax from continued operations were positive at EUR 24.9 million, while the loss from the medical business, which has been sold, had a significant negative impact as expected.
Vienna, 25 January 2024 – The Semperit Group is celebrating its 200th anniversary in 2024.
Total earnings after tax thus amounted to EUR -26.8 million (1-9 2022: EUR -34.6 million).
Vienna, 25 October 2023 – For the second time, the Semperit Group has received the highest platinum award in the EcoVadis rating for sustainability performance.
Vienna, 31 August 2023 – The Semperit Group has successfully completed the sale of its medical business to the Southeast Asian glove manufacturer HARPS GLOBAL PTE.